Market revenue in 2021 | USD 8.6 million |
Market revenue in 2030 | USD 52.4 million |
Growth rate | 22.2% (CAGR from 2021 to 2030) |
Largest segment | Oncology |
Fastest growing segment | CVD |
Historical data | 2018 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Oncology, CVD, Neurological Diseases or conditions, Metabolic diseases, Infectious diseases |
Key market players worldwide | The Carlyle Group Inc, Mendel.ai, Median Technologies, SAI.TECH Global Corp, Alphabet Inc Class A, Exscientia PLC ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to ai-based clinical trials solution provider market will help companies and investors design strategic landscapes.
Oncology was the largest segment with a revenue share of 23.26% in 2021. Horizon Databook has segmented the Japan ai-based clinical trials solution provider market based on oncology, cvd, neurological diseases or conditions, metabolic diseases, infectious diseases covering the revenue growth of each sub-segment from 2018 to 2030.
In Japan, there is a large percentage of population above 65 years of age. Hence, the government focuses on areas such as repairing damaged organ, replacing damaged organs with stem cells, and developing better cost-effective medicines.
These factors are also responsible for development of advanced solutions for clinical trials in the country. In addition, Japan is an attractive market for outsourcing for developed nations. The regulatory process is also supportive of faster clinical trial approval.
For instance, clinical trials can be started once the probable benefits are demonstrated by carrying out relatively smaller number of clinical trials. This creates opportunities for companies to enter into the market, thereby supporting local as well as international players providing technology-based solutions for clinical research.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan ai-based clinical trials solution provider market, including forecasts for subscribers. This country databook contains high-level insights into Japan ai-based clinical trials solution provider market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account